TheProfitWatch

EPRX - Eupraxia Pharmaceuticals Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
6.3 -0.03 (-0.48%) --- --- 0.0 (0.0%) --- -0.03 (-0.48%) --- ---

Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with unmet medical needs.

Category: /stock/categories/na
Market Period: Market

Earnings & Ratios

Basic EPS:
Diluted EPS:
Basic P/E:
Diluted P/E:
RSI(14) 1m:
100.0
VWAP:
6.27
RVol:

Events

Period Kind Movement Occurred At

Related News